Association of FOXO3 expression with tumor pathogenesis, prognosis and clinicopathological features in hepatocellular carcinoma: a systematic review with meta-analysis F Fondevila, P Fernandez-Palanca, C Mendez-Blanco, T Payo-Serafin, ... Cancers 13 (21), 5349, 2021 | 16 | 2021 |
Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation P Fernández-Palanca, T Payo-Serafín, B San-Miguel, C Méndez-Blanco, ... Acta pharmacologica Sinica 44 (5), 1066-1082, 2023 | 10 | 2023 |
Neuropilin-1 as a potential biomarker of prognosis and invasive-related parameters in liver and colorectal cancer: A systematic review and meta-analysis of human studies P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... Cancers 14 (14), 3455, 2022 | 8 | 2022 |
Autophagy-related chemoprotection against sorafenib in human hepatocarcinoma: Role of FOXO3 upregulation and modulation by regorafenib F Fondevila, C Méndez-Blanco, P Fernández-Palanca, T Payo-Serafín, ... International Journal of Molecular Sciences 22 (21), 11770, 2021 | 8 | 2021 |
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications P Fernández-Palanca, T Payo-Serafín, C Méndez-Blanco, B San-Miguel, ... Clinical and Molecular Hepatology 29 (2), 293, 2023 | 7 | 2023 |
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials T Payo‐Serafín, C Méndez‐Blanco, P Fernández‐Palanca, ... Clinical Pharmacology & Therapeutics, 2024 | 1 | 2024 |
180P A systematic review with meta-analysis of risks and benefits of tyrosine kinase inhibitors in hepatocellular carcinoma treatment J Martínez-Geijo, T Payo-Serafín, C Méndez-Blanco, PF Palanca, ... Annals of Oncology 35, S81, 2024 | | 2024 |
966P Potential role of neuropilin-1 in the prognosis, development and risk of invasion in hepatocellular carcinoma patients T Payo-Serafín, PF Palanca, CM Blanco, B San-Miguel, MJ Tuñón, ... Annals of Oncology 34, S601, 2023 | | 2023 |
Relevance of hypoxia-inducible factor 1 alpha in hepatocellular carcinoma: clinical and pre-clinical analysis T Payo-Serafín, P Fernández-Palanca, C Méndez-Blanco, ... Journal of Hepatology 78, S554-S555, 2023 | | 2023 |
Role of autophagy-mediated neuropilin-1 degradation on lenvatinib efficacy in human hepatocarcinoma P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... Journal of Hepatology 77, S639-S640, 2022 | | 2022 |
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies … P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
FOXO3 AS A NEW BIOMARKER FOR HUMAN HEPATOCARCINOMA: ROLE ON DIAGNOSIS, PROGNOSIS AND AUTOPHAGY-MEDIATED SORAFENIB RESISTANCE ACQUISITION F Fondevila, P Fernandez-Palanca, C Mendez-Blanco, T Payo-Serafin, ... HEPATOLOGY 74, 300A-300A, 2021 | | 2021 |
FOXO3 as a Novel Biomarker in Hepatocellular Carcinoma F Fondevila, P Fernández-Palanca, CM Blanco, T Payo-Serafín, E Lozano, ... | | |
FOXO3, Autophagy and Sorafenib Resistance in Human Hepatocarcinoma F Fondevila, CM Blanco, P Fernández-Palanca, T Payo-Serafín, ... | | |